Cerubidine, Daunorubicin, Vyxeos (daunorubicin) is a small molecule pharmaceutical. Daunorubicin was first approved as Cerubidine on 1982-01-01. It is used to treat myeloid leukemia acute and precursor cell lymphoblastic leukemia-lymphoma in the USA. It has been approved in Europe to treat myeloid leukemia acute.
|Trade Name||Vyxeos liposomal, known as Vyxeos|
|Indication||myeloid leukemia acute, precursor cell lymphoblastic leukemia-lymphoma|
|Drug Class||Antineoplastic antibiotics (daunorubicin type)|